Denise Lee
Melbourne, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Toxicity Under-Reporting in Early-Phase Plasma Cell Dyscrasia Clinical Trial Abstracts.
Journal: JCO oncology practice
Published: May 29, 2026
LTB-TREAT: A validated international prognostic model for time to treatment in low tumour burden follicular lymphoma.
Journal: British journal of haematology
Published: May 28, 2026
Underweight BMI Independently Predicts Inferior Survival in DLBCL Treated With R-CHOP: A Lymphoma Registry Study.
Journal: European journal of haematology
Published: April 14, 2026
Checkpoint inhibitors, obinutuzumab plus PET-adapted ultra-low dose nodal radiotherapy yield high efficacy in treatment-naïve follicular lymphoma: Results from the phase II 'FLUORO' study.
Journal: British journal of haematology
Published: February 16, 2026
Australasian chronic lymphocytic leukaemia consensus statement: 2026 update.
Journal: Internal medicine journal
Published: January 06, 2026
Meeting trial eligibility in Follicular lymphoma patients is associated with overall survival but not progression-free survival.
Journal: Journal of the National Cancer Institute
Published: January 07, 2025
Nivolumab and rituximab in treatment-naïve follicular lymphoma: the phase 2 1st FLOR study.
Journal: Blood advances
Published: November 27, 2024
International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin Lymphoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 26, 2024
Australian experience with ibrutinib in patients with relapsed/refractory mantle cell lymphoma: a study from the Lymphoma and Related Diseases Registry.
Journal: Leukemia & lymphoma
Published: February 20, 2024
Last Updated: 09/26/2026